These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 25950622

  • 1. Neuroaxonal dystrophy in PLA2G6 knockout mice.
    Sumi-Akamaru H, Beck G, Kato S, Mochizuki H.
    Neuropathology; 2015 Jun; 35(3):289-302. PubMed ID: 25950622
    [Abstract] [Full Text] [Related]

  • 2. Neuroaxonal dystrophy in calcium-independent phospholipase A2β deficiency results from insufficient remodeling and degeneration of mitochondrial and presynaptic membranes.
    Beck G, Sugiura Y, Shinzawa K, Kato S, Setou M, Tsujimoto Y, Sakoda S, Sumi-Akamaru H.
    J Neurosci; 2011 Aug 03; 31(31):11411-20. PubMed ID: 21813701
    [Abstract] [Full Text] [Related]

  • 3. A new PLA2G6 mutation in a family with infantile neuroaxonal dystrophy.
    Iannello G, Graziano C, Cenacchi G, Cordelli DM, Zuntini R, Papa V, Magistà AM, Gagliardi M, Procopio R, Quattrone A, Annesi G.
    J Neurol Sci; 2017 Oct 15; 381():209-212. PubMed ID: 28991683
    [Abstract] [Full Text] [Related]

  • 4. Neurons and astrocytes in an infantile neuroaxonal dystrophy (INAD) mouse model show characteristic alterations in glutamate-induced Ca2+ signaling.
    Strokin M, Reiser G.
    Neurochem Int; 2017 Sep 15; 108():121-132. PubMed ID: 28279750
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism.
    Engel LA, Jing Z, O'Brien DE, Sun M, Kotzbauer PT.
    PLoS One; 2010 Sep 23; 5(9):e12897. PubMed ID: 20886109
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in Pla2g6.
    Wada H, Yasuda T, Miura I, Watabe K, Sawa C, Kamijuku H, Kojo S, Taniguchi M, Nishino I, Wakana S, Yoshida H, Seino K.
    Am J Pathol; 2009 Dec 23; 175(6):2257-63. PubMed ID: 19893029
    [Abstract] [Full Text] [Related]

  • 11. High expression of α-synuclein in damaged mitochondria with PLA2G6 dysfunction.
    Sumi-Akamaru H, Beck G, Shinzawa K, Kato S, Riku Y, Yoshida M, Fujimura H, Tsujimoto Y, Sakoda S, Mochizuki H.
    Acta Neuropathol Commun; 2016 Mar 30; 4():27. PubMed ID: 27030050
    [Abstract] [Full Text] [Related]

  • 12. Severe disturbance in the Ca2+ signaling in astrocytes from mouse models of human infantile neuroaxonal dystrophy with mutated Pla2g6.
    Strokin M, Seburn KL, Cox GA, Martens KA, Reiser G.
    Hum Mol Genet; 2012 Jun 15; 21(12):2807-14. PubMed ID: 22442204
    [Abstract] [Full Text] [Related]

  • 13. Novel splice-site mutations and a large intragenic deletion in PLA2G6 associated with a severe and rapidly progressive form of infantile neuroaxonal dystrophy.
    Tonelli A, Romaniello R, Grasso R, Cavallini A, Righini A, Bresolin N, Borgatti R, Bassi MT.
    Clin Genet; 2010 Nov 15; 78(5):432-40. PubMed ID: 20584031
    [Abstract] [Full Text] [Related]

  • 14. Validation of the finding of hypertrophy of the clava in infantile neuroaxonal dystrophy/PLA2G6 by biometric analysis.
    Al-Maawali A, Yoon G, Feigenbaum AS, Halliday WC, Clarke JT, Branson HM, Banwell BL, Chitayat D, Blaser SI.
    Neuroradiology; 2016 Oct 15; 58(10):1035-1042. PubMed ID: 27516098
    [Abstract] [Full Text] [Related]

  • 15. Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction.
    Kinghorn KJ, Castillo-Quan JI, Bartolome F, Angelova PR, Li L, Pope S, Cochemé HM, Khan S, Asghari S, Bhatia KP, Hardy J, Abramov AY, Partridge L.
    Brain; 2015 Jul 15; 138(Pt 7):1801-16. PubMed ID: 26001724
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of the PLA2G6 gene in neurodegenerative diseases.
    Deng X, Yuan L, Jankovic J, Deng H.
    Ageing Res Rev; 2023 Aug 15; 89():101957. PubMed ID: 37236368
    [Abstract] [Full Text] [Related]

  • 18. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN).
    Kurian MA, Morgan NV, MacPherson L, Foster K, Peake D, Gupta R, Philip SG, Hendriksz C, Morton JE, Kingston HM, Rosser EM, Wassmer E, Gissen P, Maher ER.
    Neurology; 2008 Apr 29; 70(18):1623-9. PubMed ID: 18443314
    [Abstract] [Full Text] [Related]

  • 19. Disruption of Golgi morphology and altered protein glycosylation in PLA2G6-associated neurodegeneration.
    Davids M, Kane MS, He M, Wolfe LA, Li X, Raihan MA, Chao KR, Bone WP, Boerkoel CF, Gahl WA, Toro C.
    J Med Genet; 2016 Mar 29; 53(3):180-9. PubMed ID: 26668131
    [Abstract] [Full Text] [Related]

  • 20. Progressive Axonal Degeneration of Nigrostriatal Dopaminergic Neurons in Calcium-Independent Phospholipase A2β Knockout Mice.
    Beck G, Shinzawa K, Hayakawa H, Baba K, Sumi-Akamaru H, Tsujimoto Y, Mochizuki H.
    PLoS One; 2016 Mar 29; 11(4):e0153789. PubMed ID: 27078024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.